ATTs BlueCollar Hiring Challenge Signals a Shift in the AIDriven Economy Fed Minutes Reveal Potential Rate Hikes if Inflation Persists Warn of Iran Conflict Impact Pennsylvania Moves to Halt AI Chatbot Falsely Claiming Psychiatrist License SpaceX and OpenAI IPOs Potential Valuations Could Surpass Berkshire Hathaway on Debut Professional Title Copper Tariff Speculation Resurfaces Disrupting Global Metal Flows Wholesale Inflation Accelerates Producer Price Index Surges 6 Annually in April Largest Gain Since 2022 BK Q1 2026 Earnings Strong EPS Beat Highlights Resilient Fee Income and Cost Discipline TechPrecision Corporation TPCS Q1 2026 Earnings Narrowing Losses Amid Strategic Restructuring SFST Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher LKQ Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Stock Edges Higher WABC Q1 2026 Earnings EPS Beats Estimates by 306 Stock Gains 119 TIMB Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Persist Southland Holdings Inc SLND Surges Over 12 Testing Key Resistance at 137 NovaBay Pharmaceuticals NBY Surges Over 22 to 195 Amid Renewed Investor Interest Pimco Corporate Income Strategy Fund PCN Holds Steady Near 1170 as Yield Attracts Income Seekers Churchill Downs CHDN Holds Steady Near Support After Minimal Decline Castle Biosciences CSTL Faces Pullback Amid Market Volatility Key Levels in Focus Gold Futures Rise to 159 Lakh10g Amid Weak Dollar and USIran Peace Deal Prospects Globant Q1 2026 Earnings EPS Misses Estimates Stock Declines Slightly Western Asset Bond Fund WEA Edges Higher as FixedIncome Investors Assess Rate Outlook Redwood Trust Senior Notes RWTQ Edge Lower Amid Rate Uncertainty Dominari Holdings DOMH Declines 4 as Stock Approaches Key Support at 294 Pulse Biosciences PLSE Extends Gains as Positive Momentum Builds Ladder Capital Corp LADR Holds Steady Near 1024 as Momentum Builds Design Therapeutics DSGN Slips 057 Testing Support Zone Amid Light Trading Winnebago Industries WGO Edges Higher Assessing the RV Market Leaders Recovery Potential Kiniksa Pharmaceuticals KNSA Slips 193 as Stock Tests 52 Level